Long-term outcomes and persistent toxicities following BRAF/MEK inhibitor therapy for advanced melanoma

Rachel Goodman, Lorenza Di Guardo, Andrea Maurichi, Brendan Kirwin, Adnan Khattak, Vito Vanella, Joanna Lee, Aleigha Lawless, Juliane Czapla, A. Spagnoletti, Margherita Ambrosini, Elisabeth Livingstone, Georgina V. Long, Ryan J. Sullivan, Matteo S. Carlino, Victoria Atkinson, Claudia Trojanello, Paolo A. Ascierto, Dirk Schadendorf, Lydia Warburton, Alexander M. Menzies, Mario Santinami, Douglas B. Johnson